These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24734305)

  • 1. Late onset of Crohn’s disease in familial Mediterranean fever: the necessity of anti-TNF treatment.
    Kosmidou M; Mpolotsis V; Christou L; Tsianos EV
    J Dig Dis; 2014 Feb; 15(2):102-4. PubMed ID: 24734305
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP; Chapman FA; Bellamy CO; Save V; Plevris JN; Shand AG; Whitworth C; Dhaun N
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract]   [Full Text] [Related]  

  • 3. Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?
    Sorrentino D; Nash P; Viladomiu M; Hontecillas R; Bassaganya-Riera J
    Inflamm Bowel Dis; 2014 Apr; 20(4):757-66. PubMed ID: 24572206
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcending conventional therapies: the role of biologic and other novel therapies.
    Sandborn WJ
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins.
    Bach H; Rosenfeld G; Bressler B
    J Crohns Colitis; 2012 Jun; 6(5):628-9. PubMed ID: 22398081
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature.
    Ozgocmen S; Akgul O
    Mod Rheumatol; 2011 Dec; 21(6):684-90. PubMed ID: 21567247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review.
    Takazono T; Izumikawa K; Yoshioka S; Matsuo N; Yamakawa M; Suyama N; Kohno S
    Jpn J Infect Dis; 2012; 65(5):461-4. PubMed ID: 22996229
    [No Abstract]   [Full Text] [Related]  

  • 10. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E; Pugh S; Fox R
    J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?
    Farkas K; Nagy F; Kovács L; Wittmann T; Molnár T
    J Crohns Colitis; 2013 May; 7(4):e143-5. PubMed ID: 22818164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
    Blazquez I; Gonzalez-Lama Y; Roustan G
    J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?
    Kabaçam G; Törüner M
    Turk J Gastroenterol; 2010 Mar; 21(1):107-12. PubMed ID: 20552736
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab.
    Korzenik JR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):285-301, ix. PubMed ID: 15177539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penile Crohn's disease resolved by infliximab.
    Lee Y; Lee YM; Kim MJ; Choe YH
    J Crohns Colitis; 2013 May; 7(4):e146-9. PubMed ID: 22841132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable response to composite treatment including infliximab in a case of granulomatous cheilitis with Crohn's disease.
    Koga M; Koga K; Tatsukawa R; Imafuku S
    J Dermatol; 2015 Jun; 42(6):651-2. PubMed ID: 25809090
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of metastatic Crohn's disease of the skin while on anti-TNF biologics.
    Patel AV; Jones DM; Hill JC; MacDermott RP
    Inflamm Bowel Dis; 2012 Jun; 18(6):1188-90. PubMed ID: 22294342
    [No Abstract]   [Full Text] [Related]  

  • 20. Newly Diagnosed Crohn's Disease in Patient with Familial Mediterranean Fever.
    Akar T; Dindar G; Malkoç D; Karagözoğlu K; Kılavuz B; Üstündağ Y
    Arch Iran Med; 2016 Mar; 19(3):225-8. PubMed ID: 26923897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.